Login to Your Account

Clinic Roundup

Thursday, September 27, 2012
• Pacira Pharmaceuticals Inc., of Parsippany, N.J., said it started a Phase II/III pivotal trial of pain drug Exparel (bupivacaine liposome injectable suspension) administered as a single-dose injection femoral nerve block for total knee arthroplasty surgery.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription